Laurie McGinley, Washington Post: July 20, 2018. Bayer takes Essure off the market after many years of adverse events. NCHR President backs up this action.
Read More »Author: Caroline Bradford
Bayer Will Stop Selling the Troubled Essure Birth Control Implants
Sheila Kaplan, New York Times: July 20, 2018. Bayer Pharmaceuticals has taken Essure off the market. This birth control implant has caused startling issues.
Read More »FDA Expedited Approval Process Raises Concerns About Risks
Roxanne Nelson, FDA: July 18, 2018. Expedited approval process by the FDA for drugs raises concerns for safety of consumers.
Read More »Self-Injury Is Increasing in Teenage Girls: What Can Parents Do?
Trends of self-injury on the rise in an alarming rate for adolescent females and still rising in teenage boys. Read about warning signs and get the information you may need to help your child.
Read More »To Improve Treatments, Researchers Want To Hunt For Clues In Medical Records
Richard Harris, NPR: July 15, 2018. While researchers consider using electronic medical records to improve treatments, NCHR president spreads caution.
Read More »